December 8, 2022



9.30 – 9.40Welcome addressProf. Maqsood Siddiqi, President, APOCP and Founder-Chairman, Cancer Foundation of India
9.40 – 9.55Inaugural Lecture  Dr. Soumya Swaminathan  Chief Scientist, WHO, (Virtual)
Cancer Research in LMICs
9.55 – 10.15

Guest Lecture 1


 Dr.  R. Sankaranarayanan Ex-IARC, France
Making cancer healthcare affordable: the need of the hour
10.15 – 10.35

Guest Lecture 2


Prof. Anil D’Cruz President, UICC
To Be Decided
10.35 – 11.00Keynote address

 Dr. Elisabete Weiderpass (Virtual) Director, IARC, Lyon
IARC activities and initiatives in Asia-Pacific region

11.00 - 11:30 Tea & Coffee Break

Session 1:

Cervical Cancer – Screening, Early detection & Treatment


Radhika Srinivasan, PGIMER, Chandigarh, India
Neerja Bhatla, AIIMS, New Delhi, India

11.30 – 13.00

15 mins : Plenary 1. Lynette Denny, Univ Cape Town, South Africa

Screen and treat – will this approach realistically reduce cervical cancer incidence in low resource settings?
15 mins : Plenary 2. Karen Canfell, The University of Sydney, Sydney, Australia

The interaction between HPV vaccination and cervical screening: how does vaccination change the way we think about screening?
15 mins : Plenary 3. Gultekin Murat, Hacettepe Univ. Ankara, Turkey (virtual)

HPV DNA Screening Up to Date Evidence and Mega HPV Labs
10 mins : Sagarika Rout, ICMR National Institute of Cancer Prevention and Research, Noida, India

Association of genital infections as early symptoms of cervical cancer among women tobacco users in India
10 mins : Farhin Sultana, Chittaranjan National Cancer Institute, Kolkata, India

LIMD1 targeting miR-135b-5pas biomarker for non-invasive Detection of clinically relevant preneoplastic cervical lesions
10 mins : Asima Mukhopadhyay, Cepheid India Private Limited

Point of Care NAT testing for HPV DNA
10 mins : Mel Kohn, Executive Director, Medical Affairs – Vaccines, MSD, US

The Nanovalent HPV vaccine

Q & A

13.00 - 14:00 Lunch Break

Session 2:

HPV vaccination and Prevention of Cervical Cancer


R. Sankaranarayanan, Former Head of the Screening group, International Agency for Cancer Research, Lyon, France
Bhudev C. Das, Chairman, Amity Institute of Mol. Med. & Stem Cell Research., Noida, India

14.00 – 15.30

15 mins : Plenary 4. Peter Sasieni, King’s College, London University, UK

Impact of HPV vaccination on cervical cancer incidence
15 mins : Plenary 5. Partha Basu, IARC, France

Single dose recommendation for HPV vaccine – a game changer
15 mins :Plenary 6. Gary M Clifford, IARC, France

Infection-attributable cancer burden in Asia Pacific: a focus for prevention
10 mins : Abhisikta Ghosh, National Institute of Biomedical Genomics, Kalyani, India

Identification of molecular immune subtypes of HPV16 positive cervical cancers, with divergent oncogenic phenotypes, in relation to host and viral factors
10 mins : Ritu Aggarwal, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Understanding the tissue microRNA expression profile as markers of progression in HPV infected cervix
10 mins : Shivani Desai, Serum Institute, Pune

Changing the HPV landscape with indigenous vaccine – CERVAVAC

Q & A

15.30 - 16:00 Tea & Coffee Break

Session 3:

Cancer incidence in Asia Pacific region


Prakash C Gupta, Healis Inst Pub Health, Navi Mumbai, India
Alireza Mosavi-Jarrahi, Shahid Beheshti Univ. Med Sc., Tehran, Iran

16.00– 17.30

15 mins :Plenary 7. Manami Inoue, Nat Cancer Centre, Tokyo, Japan

Epidemiology of Diabetes and the risk of Cancer
15 mins : Plenary 8. Prashant Mathur, ICMR-NCDIR, Bangalore, India

Cancer surveillance in India: Role of National Cancer Registry Program
15 mins : Plenary 9. Shalini Singh, ICMR-NICPR, Noida, India (Virtual)

Smokeless Tobacco Use among women: a neglected issue
10 mins : Shubhi Goel, Post-Graduate Institute of Dental Sciences, Rohtak, Haryana, India

Evidence mapping of Incidence, prevalence, and trends of oral cancer across the Nation
10 mins : Sonam Tulsyan, ICMR National Institute of Cancer Prevention and Research, Noida, India

Somatic Mutational Landscape of Gallbladder Cancer in North Indian Population
10 mins : Bobby Paul , All India Institute of Hygiene and Public Health, & Cancer Foundation of India, Kolkata, India

Barriers to Cancer Screening uptake under NPCDCS programme in Northeast India: Formative research results

Q & A

17.30 - Sessions CLOSE

17.30–18.30 - APOCP Executive Meet

19.30 – 21.00 - WELCOME DINNER - Plenary Speakers/Invited Guests


December 9, 2022


Session 4:

Cancer Risk Factors and Prevention


Rajesh N Sharan, Former Professor, Department of Biochemistry, NEHU,Shillong, Meghalaya, India
Sharmila Sengupta, NIBG, Kalyani, India

9.30 – 11.00

15 mins : Plenary 10. Saeid Doaei, Shahid Beheshti University of Medical Sciences, Tehran, Iran

The interactions between cancer, lifestyle, and the FTO gene
15 mins : Plenary 11. Prakash C. Gupta, Healis Inst Pub Health, Navi Mumbai, India

Burden of Tobacco and Related Cancers in India
15 mins : Plenary 12. Sharmila Sengupta, NIBG, Kalyani, India

HPV-based cervical cancer screening: transition from cross-sectional to a longitudinal approach
10 mins : Sujata Pathak, All India Institute of Medical Sciences, New Delhi, India

Association between one-carbon metabolites and risk of cervical cancer
10 mins : Dona Sinha Chittaranjan National Cancer Institute, Kolkata, India

Environmental Risk for Pro-carcinogenic Alteration in Pulmonary and Systemic Micro-environments of Exposed Population
10 mins : Isha Joshi, ICMR National Institute of Cancer Prevention and Research, Noida, India

Association between Second-hand smoke exposure and neonatal mortality in India
10 mins : Ananth Ponneri Babuharisankar,National Health Research Institute, Miaoli, Taiwan

Mitochondrial Lon interacts with ULK1-FUNDC1 at the ER-mitochondria interface to promote the mitophagy under hypoxia

Q & A

11.00 - 11:30 Tea & Coffee Break

11:30 - 12:15 General Assembly of APOCP (for APOCP members only)

11:30 - 12:15 Attend Poster Session

Session 5:

Panel Discussion

12.15– 13.00

Topic: “WHO call for the elimination of cervical cancer, its challenges, and way forward in Low- and middle-income countries.”

Neerja Bhatla (Moderator), AIIMS, India
Karen Canfell, The Univ. of Sydney, Australia
Meenu Anand, American Cancer Society, USA,
Sharmila Pimple, TMH, Mumbai, India
Partha Basu, IARC, France

13.00 - 14:00 Lunch Break

Session 6:

Breast Cancer Control – Strategy & Policy


K. Ramdas, Karkinos Heathcare, Thiruvananthapuram, India
Jayanta Chakravarty, CNCI, Kolkata, India

14.00 – 15.30

15 mins : Plenary 13. Benjamin O. Anderson, Univ Washington, USA & WHO (Virtual)

WHO Global Breast Cancer Initiative (GBCI) (Virtual)
15 mins : Plenary 14. .K. Ramdas, Karkinos Heathcare, Thiruvananthapuram, India

Breast cancer prevention – Current Status
15 mins : Plenary 15. Shruti Shukla, Open Health System Labs., USA

The Breast Cancer Data Alliance
10 mins : Susmita Mondal, Presidency University, Kolkata, India

PFKFB3: A new prognostic marker in Triple-negative breast invasive ductal carcinoma
10 mins : Maryam Gholamalizadeh, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Relationship between Breast Cancer and Dietary Inflammatory Index
10 mins : Debparna Nandy, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India

Role of histone epigenetic players in breast cancer
10 mins : Geetha Manjunath, Niramai Health Analytix Pvt. Ltd

Clinical evaluation of Thermalytix, an affordable, portable, radiation-free breast cancer screening device powered by Artificial Intelligence

Q & A

15.30 - 16:00 Tea & Coffee Break

Session 7:

Breast Cancer Control –Risk Factors and Intervention


Abhishek Shankar, AIIMS, Patna, India
Shruti Shukla, Open Health System Labs., USA

16.00 – 17.30

15 mins : Plenary 16. Nurbek Igissinov, Cent Asian Cancer Inst, Astana, Kazakhstan

Breast Cancer in Kazakhstan
15 mins : Plenary 17. Richard Muwonge, IARC, Lyon

Effectiveness of triennial screening with clinical breast examination – 14-years follow-up outcomes of randomized clinical trial in Trivandrum, India
15 mins : Plenary 18. Keun-Young Yoo, Seoul Nat Univ Coll Med, South Korea (Virtual)

Breast Cancer Screening - National Cancer Control Strategy in Korea
10 mins : Khushboo Sinha, Academy of Scientific and Innovative Research, CSIR-CDRI campus, Lucknow, India

Identification of molecular signatures for the diagnosis and prognosis of Triple Negative Breast Cancers (TNBCs)
10 mins : Ranjana Pal, Presidency University, Kolkata, India

CDH1 Protein Plays a Crucial Role in Regulating TRAIL Resistance in Breast Cancer
10 mins : Stuti Roy, Saroj Gupta Cancer Centre and Research Institute, Kolkata, India

The CUEDC2-ERα Molecular Interplay- A New Insight into Mitotic Regulation Influencing Clinical Outcome in Breast Cancer
10 mins : Arunima Biswas, University of Kalyani, Kalyani, India

Role of Phosphodiesterase 4 Inhibitor Rolipram in Regressing Breast Cancer by Modulating Hedgehog Signaling Downstream of Smoothened through Gli Ubiquitination

Q & A

Session Close 17:30


December 10, 2022


Guest Lecture 09:10 To 09:30

Session 8:

Translational Research in Cancer


Sharmila Sengupta, NIBG, Kalyani, India
Susanta Roychoudhury, IICB, Kolkata, India

9.30 – 11.00

15 mins : Plenary 19. Chinmay Kumar Panda, CNCI, Kolkata, India

Anti-tumor activities of some natural phenolic compounds
15 mins : Plenary 20. Mausumi Bharadwaj, ICMR-NICPR, Noida, India

Oral Microbiome among Smokeless Tobacco (SLT) users: A metagenomic approach for identification of Carcinogenic Potential
15 mins : Plenary 21. Ranajit Mondal, CNCI, Kolkata, India

Time Trends of HPV prevalence over last two Decades - CNCI experience
10 mins : Md Sadi Khan, Chittaranjan National Cancer Institute, Kolkata, India

Dysregulated transcriptome identification from HNSCC samples and their clinical implications
10 mins : Juhina Das, Chittaranjan National Cancer Institute, Kolkata, India

NLGP is effective to delay 4NQO mediated initiation-promotion cascade in tongue squamous cell carcinogenesis of Swiss mice by maintaining type 1 immune polarity
10 mins : Pritha Roy Choudhury, Chittaranjan National Cancer Institute, Kolkata, India

Prolonged statin treatment in hypercholesterolemic mice promotes tumour progression by affecting the dendritic cell-mediated antigen presentation pathway.
10 mins : Upma Sharma, ICMR National Institute of Cancer Prevention and Research, Noida, India

Genetic variations in the IL-10 gene associated with over expression of immunosuppressive cytokine and oral cancer risk

Q & A

11.00 - 11:30 Tea & Coffee Break

Session 9:

Novel Approaches for Cancer Prevention and Management


Rita Mulhelkar, Former Head, Genetic Engg, ACTREC, Navi Mumbai, India
Rathindranath Baral,CNCI, Kolkata, India

11.30 – 13.00

15 mins : Plenary 22. Tanuja Nesari, All India Inst of Ayurveda, New Delhi, India (Virtual)

Role of Ayurveda in prevention, treatment, and management of cancer
15 mins : Plenary 23. KV Subba Rao, Predomix, Gurgaon, India

Metabolomics-based Platform for Early Detection of Multiple Cancers
15 mins : Plenary 24. Urmi Chatterji, University of Calcutta, Kolkata, India

Targeting the smarter cells: a paradigm shift for cancer therapy
10 mins : Mohona Chakravarti, Chittaranjan National Cancer Institute, Kolkata, India

PD1-Therapy-Resistant Terminally Exhausted CD8+TILs Advances Expansion of Aggressive Cancer Stem Cells in Breast, Ovarian and Cervical Carcinoma patients
10 mins : Syed Musthapa Meeran, CSIR Central Food Technological Research Institute, Mysore, India

Epi-diet alters the homeostasis of the gut microbiome for the management of cancer therapy
10 mins : Renaissa De, Department of Biophysics, PGIMER, Chandigarh, India

Autophagic regulation of hedgehog pathway in cervical cancer stem cells
10 mins : Vaishnave S, Cancer Institute (WIA), Adyar, Chennai, India

Exploring the potential of autoantibodies as a diagnostic and prognostic biomarker for gynecological cancer

Q & A:

13.00 - 14:00 Lunch

Session 10:

Interdisciplinary Research in Cancer Prevention


Mausumi Bharadwaj, Scientist, ICMR-NICPR, Noida, UP, India
Sanghamitra Sengupta, Professor, Biochemistry, Univ of Calcutta, Kolkata, India
Rajesh N Sharan, Former Head of Biochemistry , NEHU, Shillong, India

14.00 – 15.30

10 mins : Salini Das, Chittaranjan National Cancer Institute, Kolkata, India

Aspirin down-regulates G2/M effectors to evoke mitotic catastrophe in radio-resistant cervical cells
10 mins : Ratsada Praphasawat, Department of Pathology, School of Medicine, University of Phayao, Thailand

Evaluation of cytotoxicity and efficacy of red rice bran extract on apoptosis induction in colorectal cancer cells
10 mins : Mogana Das Murtey, University Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

Paddy waste suppresses benign prostate hyperplasia in spontaneously hypertensive rats (SHR) model by inducing chemopreventive effects
10 mins : Ranodeep Chatterjee, Department of Zoology, University of Calcutta, Kolkata, India

Effect of Artemisinin in modulation of CLEC12A: A novel target for cancer therapy
10 mins : Rohit Siddhartha, Department of Biochemistry, University of Lucknow, Lucknow, India

CD105, a novel marker of diagnosis and prognosis in non-muscle invasive and muscle invasive urothelial carcinoma of bladder patients
10 mins : Tanusree Ray, ICMR- National Institute of Cholera & Enteric Diseases, Kolkata, India

Vibrio cholerae hemmagglutinin protease: A novel microtubule targeting agent to kill colon cancer cells by triggering multiple cellular proteases and proteasomal cascades and induced apoptosis in explant culture of human clinical samples
10 mins : Sukanya Ghosh, Chittaranjan National Cancer Institute, Kolkata, India

Particulate Matter 2.5 Augments pro-oncogenic drivers PI3K/AKT in exposed urban population of Kolkata
10 mins : Nilanjana Basu, Amity University, NOIDA, India

Integration of in vitro and in silico perspectives to explain the anticancer effect of Arnica Montana

Q & A

15.30 - 16:00 Tea & Coffee Break

16.00 - 16:30 Valedictory function / Best Oral and Poster Awards

16:30 Conference Ends